Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis
Barnes, J.A., LaCasce, A.S., Feng, Y., Toomey, C.E., Neuberg, D., Michaelson, J.S., Hochberg, E.P., Abramson, J.S.
Published in Annals of oncology (01.08.2011)
Published in Annals of oncology (01.08.2011)
Get full text
Journal Article
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma
Barnes, J.A., LaCasce, A.S., Zukotynski, K., Israel, D., Feng, Y., Neuberg, D., Toomey, C.E., Hochberg, E.P., Canellos, G.P., Abramson, J.S.
Published in Annals of oncology (01.04.2011)
Published in Annals of oncology (01.04.2011)
Get full text
Journal Article
5‐YEAR (Y) FOLLOW‐UP OF A PHASE 2 STUDY OF IBRUTINIB PLUS FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (IFCR) AS INITIAL THERAPY FOR YOUNGER CLL PATIENTS (PTS)
Ahn, I. E., Brander, D. M., Ren, Y., Zhou, Y., Tyekucheva, S., Walker, H. A., Black, R., Montegaard, J., Alencar, A., Shune, L., Omaira, M., Jacobson, C. A., Armand, P., Ng, S., Crombie, J., Fisher, D. C., LaCasce, A. S., Arnason, J., Hochberg, E. P., Takvorian, R. W., Abramson, J. S., Brown, J. R., Davids, M. S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Initial results of a multicenter phase 2 study of venetoclax in combination with R‐CHOP (VR‐CHOP) for patients with Richter Syndrome
Davids, M. S., Rogers, K. A., Jain, N., Tyekucheva, S., Ren, Y., Carey, C., Montegaard, J., Hajdenberg, M., Ryan, C. E., Merryman, R., Kim, A., Crombie, J., Jacobson, C. A., LaCasce, A. S., Fisher, D. C., Ahn, I. E., Parry, E. M., Brown, J. R., Thompson, P. A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON‐1 STUDY
Crosswell, H. E, LaCasce, A. S., Bartlett, N. L, Straus, D. J, Savage, K. J, Zinzani, P. L, Collins, G. P, Fanale, M. A, Fenton, K, Dong, C, Miao, H. H, Grigg, A. P
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)
LaCasce, A. S., Dockter, T., Ruppert, A., Kostakoglu, L., Schöder, H., Hsi, E. D., Bogart, J. A., Cheson, B. D., Wagner‐Johnston, N. D., Abramson, J. S., Maddocks, K. J., Leonard, J. P., Bartlett, N. L.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
MATURE RESULTS FROM A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN PLUS ADRIAMYCIN AND DACARBAZINE WITHOUT RADIATION IN NON‐BULKY LIMITED STAGE CLASSICAL HODGKIN LYMPHOMA
Abramson, J. S., Bengston, E. M., Redd, R., Barnes, J. A., Takvorian, T., Sokol, L., Lansigan, F., Armand, P., Shah, B., Jacobsen, E., Martignetti, R., Turba, E., Metzler, S. R., Patterson, V., LaCasce, A. S., Bello, C. M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
90Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
Abou-Nassar, K E, Stevenson, K E, Antin, J H, McDermott, K, Ho, V T, Cutler, C S, LaCasce, A S, Jacobsen, E D, Fisher, D C, Soiffer, R J, Alyea, E P, Koreth, J, Freedman, A S
Published in Bone marrow transplantation (Basingstoke) (01.12.2011)
Published in Bone marrow transplantation (Basingstoke) (01.12.2011)
Get full text
Journal Article
Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
Henrich, Timothy J., Hu, Zixin, Li, Jonathan Z., Sciaranghella, Gaia, Busch, Michael P., Keating, Sheila M., Gallien, Sebastien, Lin, Nina H., Giguel, Francoise F., Lavoie, Laura, Ho, Vincent T., Armand, Philippe, Soiffer, Robert J., Sagar, Manish, LaCasce, Ann S., Kuritzkes, Daniel R.
Published in The Journal of infectious diseases (01.06.2013)
Published in The Journal of infectious diseases (01.06.2013)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Davids, M S, Rogers, K A, Jain, N, Tyekucheva, S, Ren, Y, Carey, C, Montegaard, J, Hajdenberg, M, Ryan, C E, Merryman, R, Kim, A, Crombie, J, Jacobson, C A, LaCasce, A S, Fisher, D C, Ahn, I E, Parry, E M, Brown, J R, Thompson, P A
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma
Barnes, Jeffrey A, Jacobsen, Eric, Feng, Yang, Freedman, Arnold, Hochberg, Ephraim P, LaCasce, Ann S, Armand, Philippe, Joyce, Robin, Sohani, Aliyah R, Rodig, Scott J, Neuberg, Donna, Fisher, David C, Abramson, Jeremy S
Published in Haematologica (Roma) (01.04.2013)
Published in Haematologica (Roma) (01.04.2013)
Get full text
Journal Article
A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND β‐GLUCAN PGG IN RELAPSED/REFRACTORY INDOLENT B‐CELL NON‐HODGKIN LYMPHOMA
Jacobson, C.A., Redd, R., Reynolds, C., Fields, M., Armand, P., Fisher, D.C., Jacobsen, E.D., LaCasce, A.S., Bose, N., Ottoson, N., Freedman, A.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Brown, Jennifer R, Messmer, Bradley, Werner, Lillian, Davids, Matthew S, Mikler, Evgeny, Supko, Jeffrey G, Fisher, David C, LaCasce, Ann S, Armand, Philippe, Jacobsen, Eric, Dalton, Virginia, Tesar, Bethany, Fernandes, Stacey M, McDonough, Sean, Ritz, Jerome, Rassenti, Laura, Kipps, Thomas J, Neuberg, Donna, Freedman, Arnold S
Published in Haematologica (Roma) (01.06.2013)
Published in Haematologica (Roma) (01.06.2013)
Get full text
Journal Article
super(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
Abou-Nassar, K E, Stevenson, K E, Antin, J H, McDermott, K, Ho, V T, Cutler, C S, LaCasce, A S, Jacobsen, E D, Fisher, D C, Soiffer, R J, Alyea, E P, Koreth, J, Freedman, A S
Published in Bone marrow transplantation (Basingstoke) (01.12.2011)
Published in Bone marrow transplantation (Basingstoke) (01.12.2011)
Get full text
Journal Article
Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
Abou-Nassar, K E, Stevenson, K E, Antin, J H, McDermott, K, Ho, V T, Cutler, C S, LaCasce, A S, Jacobsen, E D, Fisher, D C, Soiffer, R J, Alyea, E P, Koreth, J, Freedman, A S
Published in Bone marrow transplantation (Basingstoke) (01.12.2011)
Published in Bone marrow transplantation (Basingstoke) (01.12.2011)
Get full text
Journal Article
Reliability of data collection for the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multi-center outcomes database: A methodological approach
Kho, M. E., Lepisto, E. M., Niland, J. C., terVeer, A., LaCasce, A. S., Friedberg, J. W., Weeks, J. C.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies
Wilson, W. H., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Dunleavy, K., Krivoshik, A. P., Xiong, H., Chiu, Y., O’Connor, O. A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes
Feuerhake, Friedrich, Kutok, Jeffery L., Monti, Stefano, Chen, Wen, LaCasce, Ann S., Cattoretti, Giorgio, Kurtin, Paul, Pinkus, Geraldine S., de Leval, Laurence, Harris, Nancy L., Savage, Kerry J., Neuberg, Donna, Habermann, Thomas M., Dalla-Favera, Riccardo, Golub, Todd R., Aster, Jon C., Shipp, Margaret A.
Published in Blood (15.08.2005)
Published in Blood (15.08.2005)
Get full text
Journal Article
INTERIM RESULTS FROM a PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
Herrera, A.F., Moskowitz, A.J., Bartlett, N.L., Vose, J.M., Ramchandren, R., Feldman, T.A., Lacasce, A.S., Ansell, S.M., Moskowitz, C.H., Fenton, K., Ogden, C., Taft, D., Zhang, Q., Kato, K., Campbell, M., Advani, R.H.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article